OBGC
O'Brien Greene & Co Portfolio holdings
AUM
$306M
This Quarter Return
+7.88%
1 Year Return
+18.91%
3 Year Return
+60.12%
5 Year Return
+129.45%
10 Year Return
–
AUM
$280M
AUM Growth
+$280M
(+11%)
Cap. Flow
+$11.4M
Cap. Flow
% of AUM
4.08%
Top 10 Holdings %
Top 10 Hldgs %
29.46%
Holding
140
New
12
Increased
60
Reduced
27
Closed
4
Top Buys
| 1 |
AVID
Avid Technology Inc
AVID
|
$1.41M |
| 2 |
MGI
MoneyGram International, Inc. New
MGI
|
$1.28M |
| 3 |
Apple
AAPL
|
$1.11M |
| 4 |
Digital Realty Trust
DLR
|
$1.01M |
| 5 |
Dollar Tree
DLTR
|
$878K |
Top Sells
| 1 |
The Joint Corp
JYNT
|
$842K |
| 2 |
Lowe's Companies
LOW
|
$727K |
| 3 |
HealthEquity
HQY
|
$564K |
| 4 |
SHSP
SharpSpring, Inc.
SHSP
|
$368K |
| 5 |
Aflac
AFL
|
$346K |
Sector Composition
| 1 | Technology | 18.71% |
| 2 | Healthcare | 13.64% |
| 3 | Financials | 10.97% |
| 4 | Consumer Staples | 9.63% |
| 5 | Materials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lumen
LUMN
$4.92B
| $567K | 0.2% |
+41,695
| New | +$567K |
|
77
SPDR S&P MidCap 400 ETF Trust
MDY
$23.6B
| $551K | 0.2% |
1,122
| – | – |
|
78
Starbucks
SBUX
$102B
| $532K | 0.19% |
4,760
-2,375
| -33% | -$265K |
|
79
Vanguard Dividend Appreciation ETF
VIG
$95B
| $517K | 0.18% |
+3,343
| New | +$517K |
|
80
Bristol-Myers Squibb
BMY
$96.5B
| $509K | 0.18% |
7,610
| – | – |
|
81
Novartis
NVS
$245B
| $508K | 0.18% |
5,574
| – | – |
|
82
Towne Bank
TOWN
$2.74B
| $488K | 0.17% |
16,042
| – | – |
|
83
Sprott Junior Gold Miners ETF
SGDJ
$220M
| $485K | 0.17% |
11,000
| – | – |
|
84
Ulta Beauty
ULTA
$23.9B
| $484K | 0.17% |
1,400
| – | – |
|
85
Teck Resources
TECK
$16.4B
| $478K | 0.17% |
20,750
+3,200
| +18% | +$73.7K |
|
86
iShares Russell 2000 Value ETF
IWN
$11.7B
| $477K | 0.17% |
2,875
-200
| -7% | -$33.2K |
|
87
Pfizer
PFE
$142B
| $471K | 0.17% |
12,016
| – | – |
|
88
iShares Core S&P 500 ETF
IVV
$657B
| $457K | 0.16% |
1,062
-462
| -30% | -$199K |
|
89
Vanguard Small-Cap ETF
VB
$66.1B
| $445K | 0.16% |
+1,975
| New | +$445K |
|
90
CVS Health
CVS
$94B
| $440K | 0.16% |
5,275
+275
| +6% | +$22.9K |
|
|
91
HealthEquity
HQY
$7.68B
| $435K | 0.16% |
5,400
-7,000
| -56% | -$564K |
|
92
Procter & Gamble
PG
$370B
| $434K | 0.15% |
3,214
+1,200
| +60% | +$162K |
|
93
Black Stone Minerals
BSM
$2.58B
| $430K | 0.15% |
40,000
| – | – |
|
94
Merck
MRK
$214B
| $423K | 0.15% |
5,445
| – | – |
|
95
PotlatchDeltic
PCH
$3.15B
| $417K | 0.15% |
7,850
+1,150
| +17% | +$61.1K |
|
96
Newmont
NEM
$83.3B
| $412K | 0.15% |
6,500
+500
| +8% | +$31.7K |
|
97
Linde
LIN
$222B
| $405K | 0.14% |
1,400
| – | – |
|
98
Crown Castle
CCI
$42.7B
| $399K | 0.14% |
2,046
| – | – |
|
99
Diageo
DEO
$61.5B
| $384K | 0.14% |
2,005
+340
| +20% | +$65.1K |
|
100
Altria Group
MO
$113B
| $384K | 0.14% |
8,062
| – | – |
|